New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk

from Neurology Today in 5 · host Neurology Today

In this episode, editor in chief Joseph E. Safdieh, MD, FAAN, highlights articles about a new selective dopamine agonist for people with Parkinson's disease, the use of artificial intelligence in preparing journal manuscripts, and caffeinated coffee's role in reducing dementia risk.

Episode metadata supplied by the publisher feed · Published May 21, 2026

Embed this episode

Attribution link and audio player

NOW PLAYING

New Dopamine Agonist for Parkinson's, Artificial Intelligence in Medical Journals, Coffee and Dementia Risk

0:00 4:32

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Neurology Today in 5?

This episode is 4 minutes long.

When was this Neurology Today in 5 episode published?

This episode was published on May 21, 2026.

Can I download this Neurology Today in 5 episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!